Immunotherapy: Engineered T cells for all

Nature Reviews Cancer 17, 206 (2017). doi:10.1038/nrc.2017.19 Author: Gemma K. Alderton A report in Science Translational Medicine provides the first example of using universal engineered chimeric antigen receptor (CAR) T cells from human leukocyte antigen (HLA)-mismatched donors.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Research Highlight Source Type: research